Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

To evaluate the effects of adjuvant or neoadjuvant chemotherapy treatment on ovarian reserve for in situ breast cancer patients

Outcome Description:

Serum anti-Müllerian hormone concentration will be measured at each chemotherapy administration and 24 months follow-up after chemotherapy completion

Safety Issue:

No

Principal Investigator

Paul Barrière, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Nantes University Hospital

Authority:

France: Ministry of Health

Study ID:

BRD09/6-J

NCT ID:

NCT01114464

Start Date:

January 2010

Completion Date:

July 2011

Related Keywords:

• Ovarian Reserve
• Breast cancer
• Ovarian reserve
• Anti-Mullerian Hormone (AMH)
• Chemotherapy
• Breast Neoplasms

Name	Location